Amebiasis Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: A2BE22A08BF4EN
Market Monitor Global

Abstracts

Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.

This report contains market size and forecasts of Amebiasis Therapeutics in Global, including the following market information:

Global Amebiasis Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Amebiasis Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Metronidazole Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Amebiasis Therapeutics include Dr. Reddy’s Laboratories, Mission Pharmacal, Aceto Corporation, Mylan Pharmaceuticals, Impax Laboratories, Pfizer, Sanofi, Lupin Pharmaceuticals and Glenmark Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Amebiasis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Amebiasis Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Amebiasis Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Metronidazole
• Paromomycin
• Tinidazole
• Other

Global Amebiasis Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Amebiasis Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Pharmacy

Global Amebiasis Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Amebiasis Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Amebiasis Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Amebiasis Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Dr. Reddy’s Laboratories
• Mission Pharmacal
• Aceto Corporation
• Mylan Pharmaceuticals
• Impax Laboratories
• Pfizer
• Sanofi
• Lupin Pharmaceuticals
• Glenmark Pharmaceuticals
• Sun Pharmaceutical
• Heritage Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Amebiasis Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Amebiasis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AMEBIASIS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Amebiasis Therapeutics Market Size: 2021 VS 2028
2.2 Global Amebiasis Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Amebiasis Therapeutics Players in Global Market
3.2 Top Global Amebiasis Therapeutics Companies Ranked by Revenue
3.3 Global Amebiasis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Amebiasis Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Amebiasis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Amebiasis Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Amebiasis Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Amebiasis Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Amebiasis Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Metronidazole
  4.1.3 Paromomycin
  4.1.4 Tinidazole
  4.1.5 Other
4.2 By Type - Global Amebiasis Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Amebiasis Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Amebiasis Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Amebiasis Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Amebiasis Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Pharmacy
5.2 By Application - Global Amebiasis Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Amebiasis Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Amebiasis Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Amebiasis Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Amebiasis Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Amebiasis Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Amebiasis Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Amebiasis Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Amebiasis Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Amebiasis Therapeutics Revenue, 2017-2028
  6.3.2 US Amebiasis Therapeutics Market Size, 2017-2028
  6.3.3 Canada Amebiasis Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Amebiasis Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Amebiasis Therapeutics Revenue, 2017-2028
  6.4.2 Germany Amebiasis Therapeutics Market Size, 2017-2028
  6.4.3 France Amebiasis Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Amebiasis Therapeutics Market Size, 2017-2028
  6.4.5 Italy Amebiasis Therapeutics Market Size, 2017-2028
  6.4.6 Russia Amebiasis Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Amebiasis Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Amebiasis Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Amebiasis Therapeutics Revenue, 2017-2028
  6.5.2 China Amebiasis Therapeutics Market Size, 2017-2028
  6.5.3 Japan Amebiasis Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Amebiasis Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Amebiasis Therapeutics Market Size, 2017-2028
  6.5.6 India Amebiasis Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Amebiasis Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Amebiasis Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Amebiasis Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Amebiasis Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Amebiasis Therapeutics Market Size, 2017-2028
  6.7.3 Israel Amebiasis Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Amebiasis Therapeutics Market Size, 2017-2028
  6.7.5 UAE Amebiasis Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Dr. Reddy’s Laboratories
  7.1.1 Dr. Reddy’s Laboratories Corporate Summary
  7.1.2 Dr. Reddy’s Laboratories Business Overview
  7.1.3 Dr. Reddy’s Laboratories Amebiasis Therapeutics Major Product Offerings
  7.1.4 Dr. Reddy’s Laboratories Amebiasis Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Dr. Reddy’s Laboratories Key News
7.2 Mission Pharmacal
  7.2.1 Mission Pharmacal Corporate Summary
  7.2.2 Mission Pharmacal Business Overview
  7.2.3 Mission Pharmacal Amebiasis Therapeutics Major Product Offerings
  7.2.4 Mission Pharmacal Amebiasis Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Mission Pharmacal Key News
7.3 Aceto Corporation
  7.3.1 Aceto Corporation Corporate Summary
  7.3.2 Aceto Corporation Business Overview
  7.3.3 Aceto Corporation Amebiasis Therapeutics Major Product Offerings
  7.3.4 Aceto Corporation Amebiasis Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Aceto Corporation Key News
7.4 Mylan Pharmaceuticals
  7.4.1 Mylan Pharmaceuticals Corporate Summary
  7.4.2 Mylan Pharmaceuticals Business Overview
  7.4.3 Mylan Pharmaceuticals Amebiasis Therapeutics Major Product Offerings
  7.4.4 Mylan Pharmaceuticals Amebiasis Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Mylan Pharmaceuticals Key News
7.5 Impax Laboratories
  7.5.1 Impax Laboratories Corporate Summary
  7.5.2 Impax Laboratories Business Overview
  7.5.3 Impax Laboratories Amebiasis Therapeutics Major Product Offerings
  7.5.4 Impax Laboratories Amebiasis Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Impax Laboratories Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Amebiasis Therapeutics Major Product Offerings
  7.6.4 Pfizer Amebiasis Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 Sanofi
  7.7.1 Sanofi Corporate Summary
  7.7.2 Sanofi Business Overview
  7.7.3 Sanofi Amebiasis Therapeutics Major Product Offerings
  7.7.4 Sanofi Amebiasis Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Sanofi Key News
7.8 Lupin Pharmaceuticals
  7.8.1 Lupin Pharmaceuticals Corporate Summary
  7.8.2 Lupin Pharmaceuticals Business Overview
  7.8.3 Lupin Pharmaceuticals Amebiasis Therapeutics Major Product Offerings
  7.8.4 Lupin Pharmaceuticals Amebiasis Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Lupin Pharmaceuticals Key News
7.9 Glenmark Pharmaceuticals
  7.9.1 Glenmark Pharmaceuticals Corporate Summary
  7.9.2 Glenmark Pharmaceuticals Business Overview
  7.9.3 Glenmark Pharmaceuticals Amebiasis Therapeutics Major Product Offerings
  7.9.4 Glenmark Pharmaceuticals Amebiasis Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Glenmark Pharmaceuticals Key News
7.10 Sun Pharmaceutical
  7.10.1 Sun Pharmaceutical Corporate Summary
  7.10.2 Sun Pharmaceutical Business Overview
  7.10.3 Sun Pharmaceutical Amebiasis Therapeutics Major Product Offerings
  7.10.4 Sun Pharmaceutical Amebiasis Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Sun Pharmaceutical Key News
7.11 Heritage Pharmaceuticals
  7.11.1 Heritage Pharmaceuticals Corporate Summary
  7.11.2 Heritage Pharmaceuticals Business Overview
  7.11.3 Heritage Pharmaceuticals Amebiasis Therapeutics Major Product Offerings
  7.11.4 Heritage Pharmaceuticals Amebiasis Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Heritage Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Amebiasis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Amebiasis Therapeutics Market Drivers in Global Market
Table 3. Amebiasis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Amebiasis Therapeutics in Global Market
Table 5. Top Amebiasis Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Amebiasis Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Amebiasis Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Amebiasis Therapeutics Product Type
Table 9. List of Global Tier 1 Amebiasis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Amebiasis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Amebiasis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Amebiasis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Amebiasis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Amebiasis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Amebiasis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Amebiasis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Amebiasis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Amebiasis Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Amebiasis Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Amebiasis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Amebiasis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Amebiasis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Amebiasis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Amebiasis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Dr. Reddy’s Laboratories Corporate Summary
Table 31. Dr. Reddy’s Laboratories Amebiasis Therapeutics Product Offerings
Table 32. Dr. Reddy’s Laboratories Amebiasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Mission Pharmacal Corporate Summary
Table 34. Mission Pharmacal Amebiasis Therapeutics Product Offerings
Table 35. Mission Pharmacal Amebiasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Aceto Corporation Corporate Summary
Table 37. Aceto Corporation Amebiasis Therapeutics Product Offerings
Table 38. Aceto Corporation Amebiasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Mylan Pharmaceuticals Corporate Summary
Table 40. Mylan Pharmaceuticals Amebiasis Therapeutics Product Offerings
Table 41. Mylan Pharmaceuticals Amebiasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Impax Laboratories Corporate Summary
Table 43. Impax Laboratories Amebiasis Therapeutics Product Offerings
Table 44. Impax Laboratories Amebiasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Amebiasis Therapeutics Product Offerings
Table 47. Pfizer Amebiasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Amebiasis Therapeutics Product Offerings
Table 50. Sanofi Amebiasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Lupin Pharmaceuticals Corporate Summary
Table 52. Lupin Pharmaceuticals Amebiasis Therapeutics Product Offerings
Table 53. Lupin Pharmaceuticals Amebiasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Glenmark Pharmaceuticals Corporate Summary
Table 55. Glenmark Pharmaceuticals Amebiasis Therapeutics Product Offerings
Table 56. Glenmark Pharmaceuticals Amebiasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Sun Pharmaceutical Corporate Summary
Table 58. Sun Pharmaceutical Amebiasis Therapeutics Product Offerings
Table 59. Sun Pharmaceutical Amebiasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Heritage Pharmaceuticals Corporate Summary
Table 61. Heritage Pharmaceuticals Amebiasis Therapeutics Product Offerings
Table 62. Heritage Pharmaceuticals Amebiasis Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Amebiasis Therapeutics Segment by Type in 2021
Figure 2. Amebiasis Therapeutics Segment by Application in 2021
Figure 3. Global Amebiasis Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Amebiasis Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Amebiasis Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Amebiasis Therapeutics Revenue in 2021
Figure 8. By Type - Global Amebiasis Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Amebiasis Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Amebiasis Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Amebiasis Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Amebiasis Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Amebiasis Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Amebiasis Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Amebiasis Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Amebiasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Dr. Reddy’s Laboratories Amebiasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mission Pharmacal Amebiasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Aceto Corporation Amebiasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mylan Pharmaceuticals Amebiasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Impax Laboratories Amebiasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Amebiasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Amebiasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lupin Pharmaceuticals Amebiasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Glenmark Pharmaceuticals Amebiasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sun Pharmaceutical Amebiasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Heritage Pharmaceuticals Amebiasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)